Unlike high specificity (up to 98%) of BRAF V600E in papillary thyroid carcinoma (Kimura et al, 2003; Xing, 2005), no effective genetic markers have been identified to differentiate FTC and FTA, not even a panel of gene markers. The gene discussed is BRAF; the disease is thyroid gland papillary carcinoma.